Metraipolis › archive › dc_d0dabbe67ac0

Dose-escalated icotinib in frail, older adults patients with EGFR-mutant lung adenocarcinoma: real-world efficacy and safety in a high-risk cohort — Europe PMC PMID:41479790

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41479790
DOI
10.3389/fonc.2025.1700686
License (as archived)
solo-consultazione
Archived
2026-11-07T17:50:35.457Z
SHA-256 of the archived text
ec86563ee6857281498a343a72bfdac0551f52f4e3b2c92559edf4cc47a53089
Stable URL of this page
https://metraipolis.com/documento/dc_d0dabbe67ac0

How to cite

Dose-escalated icotinib in frail, older adults patients with EGFR-mutant lung adenocarcinoma: real-world efficacy and safety in a high-risk cohort — Europe PMC PMID:41479790 — Europe PMC (en), https://europepmc.org/article/MED/41479790 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d0dabbe67ac0 (Metraipolis archive dc_d0dabbe67ac0, sha256 ec86563ee6857281498a343a72bfdac0551f52f4e3b2c92559edf4cc47a53089)
BibTeX
@misc{dcd0dabbe67ac0,
  title = {Dose-escalated icotinib in frail, older adults patients with EGFR-mutant lung adenocarcinoma: real-world efficacy and safety in a high-risk cohort — Europe PMC PMID:41479790},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41479790},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d0dabbe67ac0; sha256 ec86563ee6857281498a343a72bfdac0551f52f4e3b2c92559edf4cc47a53089},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41479790. Agents can read the archived copy with the MCP tool read_document.